Peforelin
Clinical data | |
---|---|
Trade names | Maprelin |
Other names | Lamprey GnRH-III; H-Pyr-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2; XHWSHDWKPG |
Routes of administration | Injection |
Drug class | GnRH agonist |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.223.356 |
Chemical and physical data | |
Formula | C59H74N18O14 |
Molar mass | 1259.353 g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
Peforelin (INN), or peforelin acetate, sold under the brand name Maprelin, is a gonadotropin-releasing hormone agonist (GnRH agonist) medication which is used in veterinary medicine in Europe and Canada.[1][2][3][4] It is a GnRH analogue and a synthetic peptide, specifically a decapeptide.[1][3][4] The drug was introduced for veterinary use by 2001.[5]
See also
- Gonadotropin-releasing hormone receptor § Agonists
References
- 1 2 https://www.drugs.com/international/peforelin.html
- ↑ "Maprelin XP-10 (Canada) for Animal Use".
- 1 2 Löscher W, Richter A, Potschka H (3 September 2014). Pharmakotherapie bei Haus- und Nutztieren: Begründet von W. Löscher, F.R. Ungemach und R. Kroker. Enke. pp. 435–. ISBN 978-3-8304-1251-9.
- 1 2 Rodriguez-Martinez H (1 April 2010). Control of Pig Reproduction VIII. Nottingham University Press. pp. 190–. ISBN 978-1-907284-53-3.
- ↑ http://www.sgau.ru/files/pages/846/14713368000.pdf#page=48
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.